Hemophilia: treatment options in the twenty-first century
- 1 July 2003
- journal article
- review article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 1 (7) , 1349-1355
- https://doi.org/10.1046/j.1538-7836.2003.00262.x
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- The future of recombinant coagulation factorsJournal of Thrombosis and Haemostasis, 2003
- Gene therapy: reality or myth for the global bleeding disorders community?Haemophilia, 2002
- Clinical evaluation of B-domain deleted recombinant factor VIII in previously treated patientsSeminars in Hematology, 2001
- Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vectorNature Genetics, 2000
- Guidelines on replacement therapy for haemophilia and inherited coagulation disorders in ItalyHaemophilia, 2000
- Advances toward Gene Therapy for Hemophilia at the MillenniumHuman Gene Therapy, 1999
- A new variant of Creutzfeldt-Jakob disease in the UKPublished by Elsevier ,1996
- Creutzfeldt-Jakob disease and blood transfusionThe Lancet, 1993
- The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIIINew England Journal of Medicine, 1981
- Efficacy of Prothrombin-Complex Concentrates in Hemophiliacs with Antibodies to Factor VIIINew England Journal of Medicine, 1980